Among study participants, paying a fee for home delivery and monitoring of antiretroviral therapy (ART) was highly acceptable in the context of low income...
The Department of Health considers PLHIVs under “persons with comorbidities”; meaning they should be among priority people for COVID-19 vaccination. But PLHIVs still have...
Along with successful HIV treatments, it is known that the presence of social support impacts long-term survival among men living with HIV. However, little...
Despite increased vulnerability for trans people, they are seldom included in HIV testing or prevention research, and when they are their data is rarely...
The FDA in the US approved CABENUVA as the first once-monthly, long-acting injectable (LAI) for the treatment of HIV-1 infection in adults. CABENUVA consists...